IDH2 and glioma: IDH-mutant gliomas account for a larger proportion of lower grade gliomas (80% of Central Nervous System (CNS) WHO grade 2 to 3 versus 5% of CNS WHO grade 4 gliomas) as compared to IDH-wildtype gliomas.